This translational work is typically designed to investigate clinically relevant subsets of cancer, such as platinum sensitive or platinum resistant tumors, or in PDX models with specific tumor genotypes such as BRCA1- or BRCA2-mutant models. This evidence concerns the gene BRCA1 and cancer.